These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 12075699

  • 1. Update on the management of ovarian cancer.
    Ozols RF.
    Cancer J; 2002; 8 Suppl 1():S22-30. PubMed ID: 12075699
    [Abstract] [Full Text] [Related]

  • 2. Recent advances in the management of women with ovarian cancer.
    Eltabbakh GH.
    Minerva Ginecol; 2004 Feb; 56(1):81-9. PubMed ID: 14973412
    [Abstract] [Full Text] [Related]

  • 3. Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up.
    Akeson M, Zetterqvist BM, Dahllöf K, Brännström M, Horvath G.
    Acta Obstet Gynecol Scand; 2008 Feb; 87(12):1343-52. PubMed ID: 18951208
    [Abstract] [Full Text] [Related]

  • 4. Diagnosis and management of epithelial ovarian cancer.
    Bhoola S, Hoskins WJ.
    Obstet Gynecol; 2006 Jun; 107(6):1399-410. PubMed ID: 16738170
    [Abstract] [Full Text] [Related]

  • 5. Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents.
    Ozols RF.
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S60-73. PubMed ID: 19780247
    [Abstract] [Full Text] [Related]

  • 6. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
    Trimbos JB, Vergote I, Bolis G, Vermorken JB, Mangioni C, Madronal C, Franchi M, Tateo S, Zanetta G, Scarfone G, Giurgea L, Timmers P, Coens C, Pecorelli S, EORTC-ACTION collaborators. European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm.
    J Natl Cancer Inst; 2003 Jan 15; 95(2):113-25. PubMed ID: 12529344
    [Abstract] [Full Text] [Related]

  • 7. Medical treatment of epithelial ovarian cancer.
    González-Martín AJ.
    Expert Rev Anticancer Ther; 2004 Dec 15; 4(6):1125-43. PubMed ID: 15606338
    [Abstract] [Full Text] [Related]

  • 8. Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
    Cicin I, Saip P, Eralp Y, Selam M, Topuz S, Ozluk Y, Aydin Y, Topuz E.
    Gynecol Oncol; 2008 Jan 15; 108(1):136-40. PubMed ID: 17936342
    [Abstract] [Full Text] [Related]

  • 9. Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group.
    Bamias A, Papadimitriou C, Efstathiou E, Rodolakis A, Vlahos G, Voulgaris Z, Bozas G, Fountzilas G, Aravantinos G, Razis E, Gika D, Dimopoulos MA.
    BMC Cancer; 2006 Sep 25; 6():228. PubMed ID: 16999858
    [Abstract] [Full Text] [Related]

  • 10. [Prognostic factors of ovarian cancer].
    Ochiai K.
    Gan To Kagaku Ryoho; 2006 Dec 25; 33(13):2014-9. PubMed ID: 17197745
    [Abstract] [Full Text] [Related]

  • 11. Chemotherapy for ovarian cancer: an evidence-based approach.
    Geisler JP, Manahan KJ, Wiemann MC.
    Minerva Ginecol; 2004 Dec 25; 56(6):539-45. PubMed ID: 15729206
    [Abstract] [Full Text] [Related]

  • 12. Ovarian cancer.
    Colombo N, Van Gorp T, Parma G, Amant F, Gatta G, Sessa C, Vergote I.
    Crit Rev Oncol Hematol; 2006 Nov 25; 60(2):159-79. PubMed ID: 17018256
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of ovarian cancer].
    Cianti C.
    Clin Ter; 2002 Nov 25; 153(2):135-44. PubMed ID: 12078339
    [Abstract] [Full Text] [Related]

  • 14. Advances in the management of epithelial ovarian cancer.
    Berkenblit A, Cannistra SA.
    J Reprod Med; 2005 Jun 25; 50(6):426-38. PubMed ID: 16050567
    [Abstract] [Full Text] [Related]

  • 15. Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel-platinum.
    Gronlund B, Lundvall L, Christensen IJ, Knudsen JB, Høgdall C.
    Eur J Surg Oncol; 2005 Feb 25; 31(1):67-73. PubMed ID: 15642428
    [Abstract] [Full Text] [Related]

  • 16. The results of treatment of epithelial ovarian cancer after centralisation of primary surgery. Results from North Jutland, Denmark.
    Soegaard Andersen E, Knudsen A, Svarrer T, Lund B, Nielsen K, Grove A, Tetsche M.
    Gynecol Oncol; 2005 Dec 25; 99(3):552-6. PubMed ID: 16150480
    [Abstract] [Full Text] [Related]

  • 17. Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group study.
    Gynecologic Oncology GroupBox 3079, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC 27710, USA. secor002@mc.duke.edu, Secord AA, Lee PS, Darcy KM, Havrilesky LJ, Grace LA, Marks JR, Berchuck A.
    Gynecol Oncol; 2006 Jun 25; 101(3):390-7. PubMed ID: 16551475
    [Abstract] [Full Text] [Related]

  • 18. Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: a prospectively randomized gynecologic cancer intergroup trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group and the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens.
    du Bois A, Weber B, Rochon J, Meier W, Goupil A, Olbricht S, Barats JC, Kuhn W, Orfeuvre H, Wagner U, Richter B, Lueck HJ, Pfisterer J, Costa S, Schroeder W, Kimmig R, Pujade-Lauraine E, Arbeitsgemeinschaft Gynaekologische Onkologie, Ovarian Cancer Study Group, Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens.
    J Clin Oncol; 2006 Mar 01; 24(7):1127-35. PubMed ID: 16505432
    [Abstract] [Full Text] [Related]

  • 19. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
    Chan JK, Tian C, Monk BJ, Herzog T, Kapp DS, Bell J, Young RC, Gynecologic Oncology Group.
    Cancer; 2008 May 15; 112(10):2202-10. PubMed ID: 18348296
    [Abstract] [Full Text] [Related]

  • 20. [First line chemotherapy of advanced epithelial ovarian cancer].
    Lhommé C, Even C, Morice P, Balleyguier C, Petrella M, Gouy S, Uzan C, Duvillard P, Pautier P.
    Bull Cancer; 2009 Dec 15; 96(12):1207-13. PubMed ID: 19948450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.